{
  "study_id": "GEICAM/2003-10",
  "study_title": "Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study",
  "table_name": "Table 1",
  "table_title": "Patient and Tumor Characteristics",
  "footnotes": [
    "*Premenopausal defined as menstruating women without hysterectomy during the 6 months before random assignment, women younger than age 40 years with hysterectomy, or women age 40 years or older with hysterectomy and with premenopausal LH and FSH values.",
    "†Postmenopausal/perimenopausal defined as women without hysterectomy and not menstruating during the 6 months before random assignment, women older than age 55 years with hysterectomy, or women age 55 years or younger with hysterectomy andpostmenopausal LH and FSH values.",
    "‡One patient had T1mic disease."
  ],
  "groups": [
    {
      "name": "EC-T",
      "n": 669,
      "type": "Control"
    },
    {
      "name": "ET-X",
      "n": 715,
      "type": "Experimental"
    }
  ],
  "characteristics": [
    {
      "original_label": "Median (range) age, years",
      "standardized_name": "Age",
      "unit": "years",
      "category": "Demographics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "numeric_median_iqr",
          "median": 51.0,
          "iqr_min": 27.0,
          "iqr_max": 73.0,
          "raw_string": "51 (27-73)"
        },
        {
          "group_name": "ET-X",
          "data_type": "numeric_median_iqr",
          "median": 51.0,
          "iqr_min": 25.0,
          "iqr_max": 73.0,
          "raw_string": "51 (25-73)"
        }
      ]
    },
    {
      "original_label": "Karnofsky PS",
      "standardized_name": "Karnofsky Performance Status",
      "category": "Baseline Clinical Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Karnofsky PS"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Karnofsky PS"
        }
      ]
    },
    {
      "original_label": "80",
      "standardized_name": "Karnofsky Performance Status 80",
      "category": "Baseline Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Karnofsky Performance Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 9.0,
          "percentage": 1.4,
          "raw_string": "9 (1.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 7.0,
          "percentage": 1.0,
          "raw_string": "7 (1.0)"
        }
      ]
    },
    {
      "original_label": "90",
      "standardized_name": "Karnofsky Performance Status 90",
      "category": "Baseline Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Karnofsky Performance Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 75.0,
          "percentage": 11.2,
          "raw_string": "75 (11.2)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 76.0,
          "percentage": 10.6,
          "raw_string": "76 (10.6)"
        }
      ]
    },
    {
      "original_label": "100",
      "standardized_name": "Karnofsky Performance Status 100",
      "category": "Baseline Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Karnofsky Performance Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 582.0,
          "percentage": 87.0,
          "raw_string": "582 (87.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 629.0,
          "percentage": 88.0,
          "raw_string": "629 (88.0)"
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "Karnofsky Performance Status Unknown",
      "category": "Baseline Clinical Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Karnofsky Performance Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 0.4,
          "raw_string": "3 (0.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 0.4,
          "raw_string": "3 (0.4)"
        }
      ]
    },
    {
      "original_label": "Menopausal status",
      "standardized_name": "Menopausal Status",
      "category": "Demographics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Menopausal status"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Menopausal status"
        }
      ]
    },
    {
      "original_label": "Premenopausal*",
      "standardized_name": "Premenopausal",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Menopausal Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 349.0,
          "percentage": 52.2,
          "raw_string": "349 (52.2)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 382.0,
          "percentage": 53.4,
          "raw_string": "382 (53.4)"
        }
      ]
    },
    {
      "original_label": "Postmenopausal†",
      "standardized_name": "Postmenopausal",
      "category": "Demographics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Menopausal Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 320.0,
          "percentage": 47.8,
          "raw_string": "320 (47.8)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 333.0,
          "percentage": 46.6,
          "raw_string": "333 (46.6)"
        }
      ]
    },
    {
      "original_label": "Histologic type",
      "standardized_name": "Histologic Type",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Histologic type"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Histologic type"
        }
      ]
    },
    {
      "original_label": "Invasive ductal carcinoma",
      "standardized_name": "Invasive Ductal Carcinoma",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histologic Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 567.0,
          "percentage": 84.7,
          "raw_string": "567 (84.7)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 589.0,
          "percentage": 82.4,
          "raw_string": "589 (82.4)"
        }
      ]
    },
    {
      "original_label": "Invasive lobular carcinoma",
      "standardized_name": "Invasive Lobular Carcinoma",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histologic Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 66.0,
          "percentage": 9.9,
          "raw_string": "66 (9.9)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 77.0,
          "percentage": 10.8,
          "raw_string": "77 (10.8)"
        }
      ]
    },
    {
      "original_label": "Other",
      "standardized_name": "Other Histologic Type",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histologic Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 5.4,
          "raw_string": "36 (5.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 49.0,
          "percentage": 6.8,
          "raw_string": "49 (6.8)"
        }
      ]
    },
    {
      "original_label": "Histopathologic grade",
      "standardized_name": "Histopathologic Grade",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Histopathologic grade"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Histopathologic grade"
        }
      ]
    },
    {
      "original_label": "1",
      "standardized_name": "Histopathologic Grade 1",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histopathologic Grade",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 100.0,
          "percentage": 15.0,
          "raw_string": "100 (15.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 100.0,
          "percentage": 14.0,
          "raw_string": "100 (14.0)"
        }
      ]
    },
    {
      "original_label": "2",
      "standardized_name": "Histopathologic Grade 2",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histopathologic Grade",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 307.0,
          "percentage": 45.9,
          "raw_string": "307 (45.9)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 338.0,
          "percentage": 47.2,
          "raw_string": "338 (47.2)"
        }
      ]
    },
    {
      "original_label": "3",
      "standardized_name": "Histopathologic Grade 3",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histopathologic Grade",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 235.0,
          "percentage": 35.1,
          "raw_string": "235 (35.1)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 243.0,
          "percentage": 34.0,
          "raw_string": "243 (34.0)"
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "Histopathologic Grade Unknown",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Histopathologic Grade",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 27.0,
          "percentage": 4.0,
          "raw_string": "27 (4.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 34.0,
          "percentage": 4.8,
          "raw_string": "34 (4.8)"
        }
      ]
    },
    {
      "original_label": "Breast surgery",
      "standardized_name": "Breast Surgery Type",
      "category": "Prior Treatment",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Breast surgery"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Breast surgery"
        }
      ]
    },
    {
      "original_label": "Mastectomy",
      "standardized_name": "Mastectomy",
      "category": "Prior Treatment",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Breast Surgery Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 309.0,
          "percentage": 46.2,
          "raw_string": "309 (46.2)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 327.0,
          "percentage": 45.7,
          "raw_string": "327 (45.7)"
        }
      ]
    },
    {
      "original_label": "Breast-conserving surgery",
      "standardized_name": "Breast-conserving surgery",
      "category": "Prior Treatment",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Breast Surgery Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 360.0,
          "percentage": 53.8,
          "raw_string": "360 (53.8)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 388.0,
          "percentage": 54.3,
          "raw_string": "388 (54.3)"
        }
      ]
    },
    {
      "original_label": "Axillary surgery",
      "standardized_name": "Axillary Surgery Type",
      "category": "Prior Treatment",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Axillary surgery"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Axillary surgery"
        }
      ]
    },
    {
      "original_label": "Lymphadenectomy",
      "standardized_name": "Lymphadenectomy",
      "category": "Prior Treatment",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Axillary Surgery Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 618.0,
          "percentage": 92.4,
          "raw_string": "618 (92.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 676.0,
          "percentage": 94.5,
          "raw_string": "676 (94.5)"
        }
      ]
    },
    {
      "original_label": "Sentinel node biopsy",
      "standardized_name": "Sentinel node biopsy",
      "category": "Prior Treatment",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Axillary Surgery Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 0.4,
          "raw_string": "3 (0.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 0.3,
          "raw_string": "2 (0.3)"
        }
      ]
    },
    {
      "original_label": "Both",
      "standardized_name": "Both Lymphadenectomy and Sentinel node biopsy",
      "category": "Prior Treatment",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Axillary Surgery Type",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 48.0,
          "percentage": 7.2,
          "raw_string": "48 (7.2)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 37.0,
          "percentage": 5.2,
          "raw_string": "37 (5.2)"
        }
      ]
    },
    {
      "original_label": "Median (range) tumor size, cm",
      "standardized_name": "Tumor Size",
      "unit": "cm",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "numeric_median_iqr",
          "median": 2.0,
          "iqr_min": 0.0,
          "iqr_max": 13.0,
          "raw_string": "2.0 (0.0-13)"
        },
        {
          "group_name": "ET-X",
          "data_type": "numeric_median_iqr",
          "median": 2.2,
          "iqr_min": 0.1,
          "iqr_max": 13.0,
          "raw_string": "2.2 (0.1-13)"
        }
      ]
    },
    {
      "original_label": "Pathologic tumor size",
      "standardized_name": "Pathologic Tumor Size (pT)",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Pathologic tumor size"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Pathologic tumor size"
        }
      ]
    },
    {
      "original_label": "pT1",
      "standardized_name": "pT1",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Pathologic Tumor Size (pT)",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 339.0,
          "percentage": 50.6,
          "raw_string": "339 (50.6)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 327.0,
          "percentage": 45.7,
          "raw_string": "327 (45.7)"
        }
      ]
    },
    {
      "original_label": "pT2",
      "standardized_name": "pT2",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Pathologic Tumor Size (pT)",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 294.0,
          "percentage": 44.0,
          "raw_string": "294 (44.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 351.0,
          "percentage": 49.1,
          "raw_string": "351 (49.1)"
        }
      ]
    },
    {
      "original_label": "pT3",
      "standardized_name": "pT3",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Pathologic Tumor Size (pT)",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 36.0,
          "percentage": 5.4,
          "raw_string": "36 (5.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 37.0,
          "percentage": 5.2,
          "raw_string": "37 (5.2)"
        }
      ]
    },
    {
      "original_label": "Regional lymph nodes",
      "standardized_name": "Regional Lymph Nodes (pN)",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Regional lymph nodes"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Regional lymph nodes"
        }
      ]
    },
    {
      "original_label": "pN1",
      "standardized_name": "pN1",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Regional Lymph Nodes (pN)",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 450.0,
          "percentage": 67.2,
          "raw_string": "450 (67.2)‡"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 463.0,
          "percentage": 64.8,
          "raw_string": "463 (64.8)"
        }
      ]
    },
    {
      "original_label": "pN2",
      "standardized_name": "pN2",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Regional Lymph Nodes (pN)",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 167.0,
          "percentage": 25.0,
          "raw_string": "167 (25.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 181.0,
          "percentage": 25.3,
          "raw_string": "181 (25.3)"
        }
      ]
    },
    {
      "original_label": "pN3",
      "standardized_name": "pN3",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Regional Lymph Nodes (pN)",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 52.0,
          "percentage": 7.8,
          "raw_string": "52 (7.8)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 71.0,
          "percentage": 9.9,
          "raw_string": "71 (9.9)"
        }
      ]
    },
    {
      "original_label": "Hormone receptor status",
      "standardized_name": "Hormone Receptor Status",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Hormone receptor status"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Hormone receptor status"
        }
      ]
    },
    {
      "original_label": "Negative",
      "standardized_name": "Hormone Receptor Negative",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Hormone Receptor Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 98.0,
          "percentage": 14.6,
          "raw_string": "98 (14.6)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 121.0,
          "percentage": 16.9,
          "raw_string": "121 (16.9)"
        }
      ]
    },
    {
      "original_label": "Positive",
      "standardized_name": "Hormone Receptor Positive",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Hormone Receptor Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 571.0,
          "percentage": 85.4,
          "raw_string": "571 (85.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 594.0,
          "percentage": 83.1,
          "raw_string": "594 (83.1)"
        }
      ]
    },
    {
      "original_label": "HER2 status",
      "standardized_name": "HER2 Status",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "HER2 status"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "HER2 status"
        }
      ]
    },
    {
      "original_label": "Negative",
      "standardized_name": "HER2 Negative",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "HER2 Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 592.0,
          "percentage": 88.5,
          "raw_string": "592 (88.5)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 647.0,
          "percentage": 90.5,
          "raw_string": "647 (90.5)"
        }
      ]
    },
    {
      "original_label": "Positive",
      "standardized_name": "HER2 Positive",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "HER2 Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 77.0,
          "percentage": 11.5,
          "raw_string": "77 (11.5)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 65.0,
          "percentage": 9.1,
          "raw_string": "65 (9.1)"
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "HER2 Status Unknown",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "HER2 Status",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "percentage": 0.0,
          "raw_string": "0 (0.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 3.0,
          "percentage": 0.4,
          "raw_string": "3 (0.4)"
        }
      ]
    },
    {
      "original_label": "Hormone receptor/HER2 subtype",
      "standardized_name": "Hormone Receptor/HER2 Subtype",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Hormone receptor/HER2 subtype"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Hormone receptor/HER2 subtype"
        }
      ]
    },
    {
      "original_label": "Hormone receptor positive/HER2 positive",
      "standardized_name": "Hormone Receptor Positive/HER2 Positive",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Hormone Receptor/HER2 Subtype",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 50.0,
          "percentage": 7.5,
          "raw_string": "50 (7.5)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 39.0,
          "percentage": 5.5,
          "raw_string": "39 (5.5)"
        }
      ]
    },
    {
      "original_label": "Hormone receptor positive /HER2 negative",
      "standardized_name": "Hormone Receptor Positive/HER2 Negative",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Hormone Receptor/HER2 Subtype",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 521.0,
          "percentage": 77.9,
          "raw_string": "521 (77.9)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 552.0,
          "percentage": 77.2,
          "raw_string": "552 (77.2)"
        }
      ]
    },
    {
      "original_label": "Hormone receptor negative/HER2 positive",
      "standardized_name": "Hormone Receptor Negative/HER2 Positive",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Hormone Receptor/HER2 Subtype",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 27.0,
          "percentage": 4.0,
          "raw_string": "27 (4.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 26.0,
          "percentage": 3.6,
          "raw_string": "26 (3.6)"
        }
      ]
    },
    {
      "original_label": "Hormone receptor negative/HER2 negative",
      "standardized_name": "Triple-Negative Breast Cancer",
      "category": "Tumor Characteristics",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Hormone Receptor/HER2 Subtype",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 71.0,
          "percentage": 10.6,
          "raw_string": "71 (10.6)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 95.0,
          "percentage": 13.3,
          "raw_string": "95 (13.3)"
        }
      ]
    },
    {
      "original_label": "Adjuvant endocrine therapy",
      "standardized_name": "Adjuvant Endocrine Therapy",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 567.0,
          "percentage": 84.8,
          "raw_string": "567 (84.8)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 585.0,
          "percentage": 81.8,
          "raw_string": "585 (81.8)"
        }
      ]
    },
    {
      "original_label": "Tamoxifen",
      "standardized_name": "Tamoxifen",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Adjuvant Endocrine Therapy",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 299.0,
          "percentage": 44.7,
          "raw_string": "299 (44.7)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 311.0,
          "percentage": 43.5,
          "raw_string": "311 (43.5)"
        }
      ]
    },
    {
      "original_label": "Aromatase inhibitor",
      "standardized_name": "Aromatase inhibitor",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Adjuvant Endocrine Therapy",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 187.0,
          "percentage": 28.0,
          "raw_string": "187 (28.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 184.0,
          "percentage": 25.7,
          "raw_string": "184 (25.7)"
        }
      ]
    },
    {
      "original_label": "TMX + AI",
      "standardized_name": "Tamoxifen + Aromatase inhibitor",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Adjuvant Endocrine Therapy",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 79.0,
          "percentage": 11.8,
          "raw_string": "79 (11.8)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 90.0,
          "percentage": 12.6,
          "raw_string": "90 (12.6)"
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "Adjuvant Endocrine Therapy Unknown",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Adjuvant Endocrine Therapy",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 2.0,
          "percentage": 0.3,
          "raw_string": "2 (0.3)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 0.0,
          "percentage": 0.0,
          "raw_string": "0 (0.0)"
        }
      ]
    },
    {
      "original_label": "Adjuvant trastuzumab",
      "standardized_name": "Adjuvant Trastuzumab",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": false,
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "header",
          "raw_string": "Adjuvant trastuzumab"
        },
        {
          "group_name": "ET-X",
          "data_type": "header",
          "raw_string": "Adjuvant trastuzumab"
        }
      ]
    },
    {
      "original_label": "Yes",
      "standardized_name": "Received Adjuvant Trastuzumab",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Adjuvant Trastuzumab",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 20.0,
          "percentage": 3.0,
          "raw_string": "20 (3.0)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 22.0,
          "percentage": 3.1,
          "raw_string": "22 (3.1)"
        }
      ]
    },
    {
      "original_label": "No",
      "standardized_name": "Did not receive Adjuvant Trastuzumab",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Adjuvant Trastuzumab",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 56.0,
          "percentage": 8.4,
          "raw_string": "56 (8.4)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 42.0,
          "percentage": 5.9,
          "raw_string": "42 (5.9)"
        }
      ]
    },
    {
      "original_label": "Unknown",
      "standardized_name": "Adjuvant Trastuzumab Unknown",
      "category": "Adjuvant Therapy",
      "is_sub_characteristic": true,
      "sub_characteristic_of": "Adjuvant Trastuzumab",
      "group_data": [
        {
          "group_name": "EC-T",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.1,
          "raw_string": "1 (0.1)"
        },
        {
          "group_name": "ET-X",
          "data_type": "categorical_count_percentage",
          "count": 1.0,
          "percentage": 0.1,
          "raw_string": "1 (0.1)"
        }
      ]
    }
  ]
}